Approval · Notice of Compliance 5175 · 1995

BREVICON: Notice of Compliance 5175

Issued October 31, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 5175
Date: October 31, 1995
Company: Searle Canada Inc.
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Oral contraceptive

Products in this notice

Brand	DIN	Status today
BREVICON	02187086	Marketed
BREVICON	02189054	Marketed
BREVICON	02187094	Marketed
BREVICON	02189062	Marketed

Medicinal ingredients

ETHINYL ESTRADIOL 0.035 MG per TAB
NORETHINDRONE 0.5 MG per TAB
NORETHINDRONE 1 MG per TAB